Research funding opportunities

Neuroblastoma UK invites applications for UK or Republic of Ireland (ROI) led research that will benefit children with neuroblastoma every two years.

A wide range of basic and applied research applications will be considered for funding, from studies to understand the origin and development of neuroblastomas to research that aims to develop new therapeutic approaches, improve existing treatments or explore treatment synergies.

Research that aims to establish a “proof of principle” for further research will also be considered. Grants will be evaluated by peer review and by our Scientific Advisory Board before a decision is made by the Trustee Board.

Neuroblastoma UK Grant round 2024 applications now closed.

Neuroblastoma UK invites applications across the breadth of our research remit to facilitate the development of new and improved treatments for children with neuroblastoma. Our emphasis for this grant call is on translational research which can be rapidly applied to the clinical setting in the short to medium term. We are especially interested in applications that aim to develop new therapeutic approaches, improve existing treatments or explore treatment synergies.

Full details, support docs and application form

Research grant round 2021

Thanks to your kind donations, Neuroblastoma UK awarded two research grants in 2021 totalling £683,477, with a focus on improving treatment for children with advanced stages of the disease.

Professor Louis Chesler will receive a research grant of £469,093, which includes a donation of £15,000 from charity Friends of Rosie. Professor Chesler’s research aims to develop blood-based biomarker tests for children with high-risk neuroblastoma, to help guide and monitor treatment.

Dr Mark Gaze will receive a research grant of £214,385 to develop a new type of targeted, radiotherapy using radioactive antibodies for children with high-risk neuroblastoma.

Read more: Grant Round 2021 awards announced

Research grant round 2018

Thanks to our generous supporters, we provided funding for nine new research studies in 2019, as part of our 2018 grant round, with a total funding of £1.177 million.

Research ranges from studies to understand the origin and development of neuroblastoma to research that aims to develop new therapeutic approaches or improve existing treatments.

>> Read about previously funded research projects

Small Grant Applications

Neuroblastoma UK considers applications for small amounts (under £5,000) of funding for innovative neuroblastoma research throughout the year.

Our Small Grants programme helps researchers develop projects that aim to improve our understanding of how neuroblastomas develop. This funding may then lead to form larger grant applications for novel, more effective approaches to treatment.

Please read the Guidance Notes for Small Grant applications (doc) carefully and submit your application on the Small Grants Application Form (updated January 2021).

>> Read about recently allocated small grants

Conflict of Interest

Neuroblastoma UK makes every effort to ensure that its decisions are fair, objective and transparent.

For both external reviewers and members of the Scientific Advisory Board, a conflict of interest policy is in place to seek to avoid the involvement of individuals with a conflict of interest in relation to an application through its review process.

Code of Conduct

Reviewers have a right to expect that their comments will be treated in confidence by both Neuroblastoma UK’s staff, trustees and other members of a peer review group.

Applicants should not under any circumstances, directly approach members of the Scientific Advisory Board in connection with their (or another’s) research application.

Download our Conflict of Interest and Code of Conduct Policy (PDF)

Queries

Please email grants@neuroblastoma.org.uk with any queries, allowing a few days for a response. You may also wish to look at our Research FAQ page.